Official UK procurement notice
NP47823b Multiple Sclerosis Additions
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)·Consortium: 2 public authorities
What is being bought2 lots · detail below
Published requirement descriptionSupply of multiple sclerosis medicines to NHS Scotland.
CPV: Pharmaceutical products
How this framework works
From the published notice- Places
- up to 3 suppliers · 15 bids on the busiest of 2 lots (5.0 per place) · 4 appointed (full)
- Framework period
- 1 yr 3 mo from 6 Feb 2024
Lots and requirements (2)Procurement structure
2 lots · all with a published value · same evaluation weights on every lotLot #1Teriflunomide Tablets, Dimethyl Fumarate Gastro-resistant Capsules, and Fingolimod CapsulesAwardedRenewalPublished value£20,252,307
Supply of teriflunomide tablets, dimethyl fumarate gastro resistant capsules, and fingolimod capsules to NHS Scotland. The Authority awarded the Framework Agreement as a single supplier framework agreement per product line to three (3) Framework Participants.
Lot #2Natalizumab Solution for Infusion Vials and Injection Pre-filled SyringesAwardedRenewalPublished value£12,721,376
Supply of natalizumab solution for infusion vials and injection pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a supplier framework agreement per product line to one (1) Framework Participant.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- Technical (Supply Chain) / Weighting: 5%
- price: 95%
Published award criteria (2)
- Technical (Supply Chain) / Weighting: 5
- Price: 95
- Suitability
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015
- Technical & professional ability
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the start date of the Framework Agreement.
AND
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
AND
(c) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines from the start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under t…
- Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
- “NP47823b Multiple Sclerosis Additions” is a framework: the contest is a place on its panel, up to 3 suppliers, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 3 Nov 2023, 10:05 GMT
- Last source update
- 2 Feb 2024, 11:33 GMT
- Award evaluation window
- 4 Dec 2023 – …
- FTS notice number
2024/S 000-003492- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-041184Find a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.
Publisher note: The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the fourteen (14) month Framework Agreement duration and the thirty-four (34) month extension period of the Framework Agreement. Details of individual lines awarded within a specific Lot can be requested from the named person at the head of this notice. (SC Ref:755577)
How it was run
Official notice- Appointment period ends
- 4 Dec 2023, 12:00 GMT
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bid validity
- 90 days from the deadline
- Bids opened
- 4 Dec 2023, 12:00 GMT
Timeline
4 Dec 2023 → 6 Feb 2024 · 4 dates- Admission / appointment period endsperiod end, not a bid countdown4 Dec 2023, 12:00 GMT
- Bids opened4 Dec 2023, 12:00 GMT
- Notice published2 Feb 2024, 11:33 GMT
- Contract starts6 Feb 2024
Notice history
2 events · 2 releases on Find a Tender · since 2 Feb 2024- Status changed to complete2 Feb 2024, 11:33 GMT
- Buyer details updated2 Feb 2024, 11:33 GMT
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast2 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Natalizumab Solution for Infusion Vials and Injection Pre-filled Syringes
- Signed
- 12 Jan 2024
- Value
- £17,322,900
- Period
- … – 30 Apr 2025
- Status
- active
Teriflunomide Tablets, Dimethyl Fumarate Gastro-resistant Capsules, and Fingolimod Capsules
- Signed
- 12 Jan 2024
- Value
- £17,035,260
- Period
- … – 30 Apr 2025
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · Teriflunomide Tablets, Dimethyl Fumarate Gastro-resistant Capsules, and Fingolimod Capsules | 15bids · 15 electronic · 15 from abroad | 0 | — | — |
| 2 · Natalizumab Solution for Infusion Vials and Injection Pre-filled Syringes | 1bids · 1 electronic · 1 from abroad | 0 | — | — |
Contracting authority & participating public bodies
2 public bodies on the noticeDispute resolution & review bodies
- Sheriff Court HouseReview body
Framework contractors & participating bidders
4 commercial parties on the notice- Biogen Idec LtdFramework contractor
- Ranbaxy (UK) LtdFramework contractor
- Viatris UK Healthcare LtdFramework contractor
- Wockhardt UK LimitedFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.